A Closer Look at 8 Analyst Recommendations For Merck & Co
A Closer Look at 8 Analyst Recommendations For Merck & Co
對默沙東公司的8位分析師推薦進行更詳細的分析
8 analysts have shared their evaluations of Merck & Co (NYSE:MRK) during the recent three months, expressing a mix of bullish and bearish perspectives.
在最近三個月內，8位分析師對默沙東（紐交所:MRK）進行了評估，表達了看好和看淡的觀點。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
以下表格總結了分析師們最近的評級，揭示了過去30天內情緒的變化並將其與前幾個月進行了比較。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $144.12, a high estimate of $155.00, and a low estimate of $125.00. This current average represents a 2.29% decrease from the previous average price target of $147.50.
Insights from analysts' 12-month price targets are revealed, presenting an average target of $144.12, a high estimate of $155.00, and a low estimate of $125.00. This current average represents a 2.29% decrease from the previous average price target of $147.50.
Interpreting Analyst Ratings: A Closer Look
解讀分析師評級：更深入的了解
The standing of Merck & Co among financial experts is revealed...
默克的地位在金融專家中...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。